RTA compliance certificate under SEBI Reg 74(5) for Q2 FY26 filed

Compliance View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+4.9%Reaction day

₹93.00

prior close

₹97.40

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.7%+4.2% vs market

Pharmaceuticals peers, median of 172sector-0.0%+4.9% vs sector

On the reaction day the stock moved 4.2 pts more than Nifty Microcap 250 and 4.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

+0.1

15m

+0.1

30m

+0.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+4.9+0.7+4.2-0.0+4.9

Next day

+10.1-1.0+11.1-0.8+10.9

+15.6-0.3+15.9-0.6+16.2

+21.4-1.9+23.3-1.9+23.3

+27.5-4.5+31.9-3.5+31.0

+30.1-5.5+35.6-4.4+34.5

+43.0-7.3+50.3-4.4+47.4

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Asston Pharmaceuticals filed with BSE a routine compliance certificate under Regulation 74(5) of SEBI Depositories and Participants Regulations for the quarter ended 30 September 2026. The certificate from Maashitla Securities, the company's Registrar and Share Transfer Agent, confirms that no share certificates were received from depository participants for dematerialisation, and none were rejected, during the quarter. Signed by Company Secretary Rishi Upadhaya.

Likely market impact

Routine procedural filing with no effect on operations, shareholders, or stock price.